Cheryl Santos

Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney.

J. Mackey, C. Cass, S. Baldwin, 2007, American journal of physiology. Renal physiology.

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene

J. Mackey, C. Galmarini, C. Dumontet, 2004, BMC pharmacology.

Prognostic Significance of Tissue Inhibitor of Metalloproteinase-1 in Breast Cancer

J. Mackey, Sunita Ghosh, A. Dechaphunkul, 2012, International journal of breast cancer.

Expression of nucleoside transporters and deoxycytidine kinase proteins in muscle invasive urothelial carcinoma of the bladder: correlation with pathological response to neoadjuvant platinum/gemcitabine combination chemotherapy.

J. Mackey, C. Cass, Sunita Ghosh, 2014, The Journal of urology.

Human equilibrative nucleoside transporter 1 (hENT1) in gemcitabine and FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin)-treated patients with metastatic pancreatic cancer: The randomized phase II PAN1 study.

V. Gebski, J. Mackey, D. Goldstein, 2014 .

Unexpected Immunohistochemical Localization of Deoxycytidine Kinase

J. Mackey, R. Lai, Lorelei Johnson, 2006, Clinical Cancer Research.

Use of a small reporter molecule to determine cell-surface proteins by capillary electrophoresis and laser-induced fluorescence: use of 5-SAENTA-x8f for quantitation of the human equilibrative nucleoside transporter 1 protein.

J. Mackey, C. Cass, N. Dovichi, 2002, Analytical Chemistry.